Pharma and Biotech
Positive progress on European Patent Application | 26-Mar-2025 | 07:00 | RNS |
Update on AWKN-SDN-14 programme | 18-Mar-2025 | 07:00 | RNS |
Holding(s) in Company | 11-Mar-2025 | 09:00 | RNS |
Appointment of Non-Executive Director | 11-Mar-2025 | 07:00 | RNS |
Entry into an Arrangement Agreement with Awakn | 24-Feb-2025 | 07:00 | RNS |
Update on Awakn Life Sciences’ R&D Progress | 27-Jan-2025 | 07:00 | RNS |
Update on FDA Pre-IND Meeting for Awakn | 21-Jan-2025 | 07:00 | RNS |
Change of Name to Solvonis Therapeutics plc | 14-Jan-2025 | 07:00 | RNS |
Result of General Meeting and change of name | 06-Jan-2025 | 14:27 | RNS |
Proposed acquisition of Awakn Life Sciences Corp | 16-Dec-2024 | 07:00 | RNS |
Initial Results University of Nottingham | 11-Dec-2024 | 07:00 | RNS |
Notice of GM and proposed name change | 03-Dec-2024 | 09:44 | RNS |
Research Agreement | 15-Oct-2024 | 07:00 | RNS |
Research and development update | 04-Oct-2024 | 07:00 | RNS |
Directorate Change and grant of options | 26-Sep-2024 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 0.16p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 1.01p |
52 Week Low | 0.12p |
Volume | 29,115,498 |
Shares Issued | 2,295.93m |
Market Cap | £3.62m |
Beta | 0.08 |
Value | ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:09 | 682,578 @ 0.16p |
14:24 | 185,000 @ 0.16p |
13:32 | 5,000,000 @ 0.16p |
13:20 | 3,426,770 @ 0.16p |
12:26 | 1,000,000 @ 0.16p |
CEO | Anthony Tennyson |
Chair | Dennis Purcell |
Finance Director | Ryan Neats |
You are here: research